People with diabetes are twice as likely to develop dementia as those without the disease. In a new study, people with newly diagnosed type 2 diabetes who took the diabetes drug pioglitazone were less likely to later develop ...
Feb 15, 2023
0
35
An insulin-sensitizing drug can benefit patients with insulin resistance at lower doses than has typically been prescribed, according to a study co-authored by Paresh Dandona, MD, Ph.D., SUNY Distinguished Professor of Medicine ...
Apr 1, 2022
0
10
(HealthDay)—For insulin-resistant patients with recent ischemic stroke or transient ischemic attack, pioglitazone is associated with reduced risk of diabetes, according to a study published online July 27 in Diabetes Care.
Aug 5, 2016
0
1
Some previous studies have linked the diabetes medication pioglitazone to bladder cancer. However a new study − including more than one million people in six populations worldwide − has found no link between either pioglitazone ...
Dec 3, 2014
0
1
(HealthDay)—The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.
Jan 26, 2013
1
3
Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated ...
Jun 16, 2011
0
0
a drug used to treat type 2 diabetes - is associated with an increased risk of bladder cancer, finds a study published on BMJ today.
May 31, 2012
0
0
(HealthDay) -- Thiazolidinediones are associated with a lower risk of liver and colorectal cancer in patients with type 2 diabetes, according to a study published in the May issue of Hepatology.
Apr 27, 2012
0
0
A drug commonly used to treat Type II diabetes abolishes the characteristic signs of nicotine withdrawal in rats and mice, according to new research published in JNeurosci. The finding may offer an important new strategy ...
Nov 4, 2019
0
2
Treating people with type 2 diabetes, also known as 'age-related diabetes' with antidiabetics reduces their risk for Alzheimer's and other types of dementia. The risk is most significantly reduced by the drug pioglitazone. ...
Jun 23, 2015
0
49
Pioglitazone is a prescription drug of the class thiazolidinedione (TZD) with hypoglycemic (antihyperglycemic, antidiabetic) action. Pioglitazone is marketed as trademarks Actos in the USA, Canada, the UK and Germany, Glustin in Europe,"Glizone" and "Pioz" in India by Zydus CND and USV respectively and Zactos in Mexico by Takeda Pharmaceuticals. Actos was the tenth-best selling drug in the U.S. in 2008, with sales exceeding $2.4 billion. Its cardiovascular safety profile compares favorably with rosiglitazone (Avandia), which was withdrawn after concerns about an increased risk of cardiac events, but pioglitazone has subsequently been found to be associated with bladder tumors and has been withdrawn in some countries.
This text uses material from Wikipedia, licensed under CC BY-SA
